APPLICATION
ANDA074481
TYPE
ANDA
ORIGINAL APPROVAL
1996-02-13
LATEST ACTION
2024-08-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CAPTOPRILDiscontinued
CAPTOPRIL 50MG · TABLET · ORAL
CAPTOPRILDiscontinued
CAPTOPRIL 12.5MG · TABLET · ORAL
CAPTOPRILDiscontinued
CAPTOPRIL 100MG · TABLET · ORAL
CAPTOPRILDiscontinued
CAPTOPRIL 25MG · TABLET · ORAL
Approval history
2024-08-13Labeling · Supplement 4 · standardAP
2024-08-13Labeling · Supplement 3 · standardAP
1997-09-05Labeling · Supplement 2AP
1997-06-10Labeling · Supplement 1AP
1996-02-13OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.